Sign In
Buy BTX
$8.05
+0.150 (+1.90%)
At Close: Jul 31, 2026
Brooklyn ImmunoTherapeutics Set to Join Russell 3000 Index
07:30am, Wednesday, 09'th Jun 2021
BROOKLYN, N.Y., June 09, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene
Brooklyn ImmunoTherapeutics Welcomes Dr. Kevin A. D'Amour as Chief Scientific Officer
07:30am, Tuesday, 08'th Jun 2021
BROOKLYN, N.Y., June 08, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene
Brooklyn Immunotherapeutics Stock Is a Worthy Bet on Genetics Research
04:27pm, Monday, 07'th Jun 2021
BTX stock holders will certainly want to brace for volatility. Still, the outlook's bullish as the company pursues its game-changing research.
Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company's Future During May 25, 2021 Shareholder Update Call
02:03pm, Wednesday, 26'th May 2021
BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics CEO Howard J. Federoff Provides Roadmap for the Company's Future During May 25, 2021 Shareholder Update Call
BTX Stock Price: 21.02% Increase Explanation
04:24pm, Monday, 24'th May 2021
The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) increased by 21.02% today. This is why it happened.
Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing
02:58pm, Monday, 24'th May 2021
BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics Strengthens Investment in Licensed mRNA Technology Platform with $20M Financing
Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.
07:30am, Friday, 21'st May 2021
BROOKLYN, N.Y.--(BUSINESS WIRE)--Michael Andreeff, M.D., Ph.D to Join the Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.
New CEO and Exclusive License Will Bolster Brooklyn Immunotherapeutics
02:03pm, Tuesday, 18'th May 2021
Is change at the C-suite level a good thing for a company? The facts seem to indicate that it's a positive development for BTX stock holders.
Christopher Rohde, Ph.D. to Join Scientific Advisory Board of Brooklyn ImmunoTherapeutics, Inc.
07:30am, Thursday, 13'th May 2021
BROOKLYN, N.Y.--(BUSINESS WIRE)--Brooklyn ImmunoTherapeutics announces the appointment of Christopher Rohde, Ph.D. to the Company's Scientific Advisory Board
Publication In Breast Cancer Research Indicate Brooklyn ImmunoTherapeutics' IRX-2 May Hold Promise In Early-Stage Breast Cancer
12:56pm, Tuesday, 11'th May 2021
Brooklyn ImmunoTherapeutics Inc (NYSE: BTX) has announced a publication in Breast Cancer Research, which demonstrates how multiplex immunofluorescence (mIF) may be used to characterize the immunol
Why Brooklyn ImmunoTherapeutics Stock Crushed It in April
02:09pm, Saturday, 08'th May 2021
This clinical-stage biotech was one of April's brightest stars.
Up 1,300% in the Past Month, Is This Mysterious Biotech a Buy?
06:25am, Wednesday, 05'th May 2021
An unknown biotech has turned its early investors into millionaires over the past month. Can it continue its momentum?
BTX Stock: From $49.80 To Over $82 Pre-Market Explanation
05:14am, Monday, 03'rd May 2021
The stock price of Brooklyn Immunotherapeutics Inc (NYSEAMERICAN: BTX) increased from over 64% pre-market as it went from $49.80 to over $82 pre-market. This is why it happened.
Brooklyn Immuno Therapeutics Skyrockets: Technical Levels To Watch
03:07pm, Friday, 30'th Apr 2021
Brooklyn Immuno Therapeutics Inc. (NYSE: BTX) shares are soaring Friday. The stock is likely continuing its run after the company paid $1 million towards the acquisition of a license for Factor Biosc
BTX Stock: The Big News That Has Brooklyn ImmunoTherapeutics Rocketing Higher
03:02pm, Friday, 30'th Apr 2021
Today, investors in BTX stock appear to be on board in a big way with a major announcement from this hot meme stock and Reddit favorite. The post BTX Stock: The Big News That Has Brooklyn ImmunoTherap
